Go to JCI Insight
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Alerts
  • Advertising
  • Job board
  • Subscribe
  • Contact
  • Current issue
  • Past issues
  • By specialty
    • COVID-19
    • Cardiology
    • Gastroenterology
    • Immunology
    • Metabolism
    • Nephrology
    • Neuroscience
    • Oncology
    • Pulmonology
    • Vascular biology
    • All ...
  • Videos
    • Conversations with Giants in Medicine
    • Author's Takes
  • Reviews
    • View all reviews ...
    • Next-Generation Sequencing in Medicine (Upcoming)
    • New Therapeutic Targets in Cardiovascular Diseases (Mar 2022)
    • Immunometabolism (Jan 2022)
    • Circadian Rhythm (Oct 2021)
    • Gut-Brain Axis (Jul 2021)
    • Tumor Microenvironment (Mar 2021)
    • 100th Anniversary of Insulin's Discovery (Jan 2021)
    • View all review series ...
  • Viewpoint
  • Collections
    • In-Press Preview
    • Commentaries
    • Concise Communication
    • Editorials
    • Viewpoint
    • Top read articles
  • Clinical Medicine
  • JCI This Month
    • Current issue
    • Past issues

  • Current issue
  • Past issues
  • Specialties
  • Reviews
  • Review series
  • Conversations with Giants in Medicine
  • Author's Takes
  • In-Press Preview
  • Commentaries
  • Concise Communication
  • Editorials
  • Viewpoint
  • Top read articles
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Alerts
  • Advertising
  • Job board
  • Subscribe
  • Contact
Responses against islet antigens in NOD mice are prevented by tolerance to proinsulin but not IGRP
Balasubramanian Krishnamurthy, … , Helen E. Thomas, Thomas W.H. Kay
Balasubramanian Krishnamurthy, … , Helen E. Thomas, Thomas W.H. Kay
Published December 1, 2006
Citation Information: J Clin Invest. 2006;116(12):3258-3265. https://doi.org/10.1172/JCI29602.
View: Text | PDF
Research Article Metabolism

Responses against islet antigens in NOD mice are prevented by tolerance to proinsulin but not IGRP

  • Text
  • PDF
Abstract

Type 1 diabetes (T1D) is characterized by immune responses against several autoantigens expressed in pancreatic β cells. T cells specific for proinsulin and islet-specific glucose-6-phosphatase catalytic subunit–related protein (IGRP) can induce T1D in NOD mice. However, whether immune responses to multiple autoantigens are caused by spreading from one to another or whether they develop independently of each other is unknown. As cytotoxic T cells specific for IGRP were not detected in transgenic NOD mice tolerant to proinsulin, we determined that immune responses against proinsulin are necessary for IGRP-specific T cells to develop. On the other hand, transgenic overexpression of IGRP resulted in loss of intra-islet IGRP-specific T cells but did not protect NOD mice from insulitis or T1D, providing direct evidence that the response against IGRP is downstream of the response to proinsulin. Our results suggest that pathogenic proinsulin-specific immunity in NOD mice subsequently spreads to other antigens such as IGRP.

Authors

Balasubramanian Krishnamurthy, Nadine L. Dudek, Mark D. McKenzie, Anthony W. Purcell, Andrew G. Brooks, Shane Gellert, Peter G. Colman, Leonard C. Harrison, Andrew M. Lew, Helen E. Thomas, Thomas W.H. Kay

×

Figure 4

Expression of IGRP in NOD-IGRP mice.

Options: View larger image (or click on image) Download as PowerPoint
Expression of IGRP in NOD-IGRP mice.
(A) Expression of transgenic IGRP m...
(A) Expression of transgenic IGRP mRNA in the thymi of NOD-IGRP or nontransgenic control littermates as compared with IGRP mRNA in islets of NOD mice. Total RNA from NOD-IGRP mice and nontransgenic control littermates was reverse transcribed using random primers. Real-time RT-PCR was performed with Assay-on-Demand kits for mouse IGRP and β-actin. (B) Functional IGRP expression in APCs of NOD-IGRP mice. CD8+ T cells from a NOD8.3 mouse were labeled with CFSE and transferred into 6-week-old NOD-IGRP or nontransgenic control littermates (n = 4 per group). Recipients were sacrificed 3 days later, and their PLNs and ILNs were examined for CFSE+ cells. The numbers within the histogram plots indicate percentages of CFSE-low cells.

Copyright © 2022 American Society for Clinical Investigation
ISSN: 0021-9738 (print), 1558-8238 (online)

Sign up for email alerts